Ridley Life Science Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 8.28 Cr
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.44 Cr
- Satisfied Charges ₹ 2.98 Cr
- Revenue Growth -45.57%
- Profit Growth -154.60%
- Ebitda -16.00%
- Net Worth -1.72%
- Total Assets -37.71%
About Ridley Life Science
Ridley Life Science Private Limited (RLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 September 2004 and has a history of 20 years and four months. Its registered office is in Delhi, India.
The Corporate was formerly known as Torex Pharmaceuticals Private Limied. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.28 Cr.
The company currently has active open charges totaling ₹24.44 Cr. The company has closed loans amounting to ₹2.98 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Bansal, Rakesh Bansal, and Ram Gautam serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232DL2004PTC129295
-
Company No.
129295
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Sep 2004
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Ridley Life Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Bansal
|
Director | 21-Sep-2004 | Current |
|
Rakesh Bansal
|
Director | 21-Sep-2004 | Current |
|
Ram Gautam
|
Director | 15-Nov-2019 | Current |
Financial Performance of Ridley Life Science.
Ridley Life Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 45.57% decrease. The company also saw a substantial fall in profitability, with a 154.6% decrease in profit. The company's net worth dipped by a decrease of 1.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ridley Life Science?
In 2023, Ridley Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aisen Lifesciences LlpRajesh Bansal is a mutual person
-
Meczen Biogenics Llp
Rajesh Bansal is a mutual person
-
Mackly Life Science Private Limited
Rajesh Bansal is a mutual person
-
Macred Enterprises Llp
Rakesh Bansal is a mutual person
-
Accrenia Enterprises Llp
Rakesh Bansal is a mutual person
-
Acrecia Ventures Private Limited
Rakesh Bansal is a mutual person
Charges (Loans)
₹24.44 Cr
₹2.98 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 16.94 Cr
- Bank Of Baroda : 7.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2020 | Axis Bank Limited | ₹16.94 Cr | Open |
| 15 Jun 2012 | Bank Of Baroda | ₹7.50 Cr | Open |
| 19 May 2020 | Others | ₹5.50 M | Satisfied |
| 11 Apr 2017 | Hdfc Bank Limited | ₹1.85 Cr | Satisfied |
| 31 Dec 2013 | Intec Capital Limited | ₹5.78 M | Satisfied |
How Many Employees Work at Ridley Life Science?
Ridley Life Science has a workforce of 30 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ridley Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ridley Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.